Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bruggeman

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Case Reports in Psychiatry|August 31, 2012
The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case ReportKhalid Abou Farha, Andre van Vliet, Henderikus Knegtering, et al.
BMC Psychiatry|March 23, 2017
Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illnessAnne Looijmans, Frederike Jörg, Richard Bruggeman, et al.
Schizophrenia Bulletin|August 23, 2015
Creating a Supportive Environment: Peer Support Groups for Psychotic DisordersStynke Castelein, Richard Bruggeman, Larry Davidson, et al.
BMC Psychiatry|November 7, 2019
Multimodal lifestyle intervention using a web-based tool to improve cardiometabolic health in patients with serious mental illness: results of a cluster randomized controlled trial (LION)Anne Looijmans, Frederike Jörg, Richard Bruggeman, et al.
Journal of Neuro-Oncology|September 8, 2010
The detection of CMV pp65 and IE1 in glioblastoma multiformeKenneth G Lucas, Lei Bao, Richard Bruggeman, et al.
Neuropsychology|February 17, 2026
Financial competence, situation, and context of people with recent-onset psychosis: A comparison with matched controls and the role of cognitionJosephien Leonie Jansen, Lydia Krabbendam, Oliver Tucha, et al.
International Journal of Qualitative Studies on Health and Well-Being|March 20, 2025
A penny for your thoughts: three perspectives on financial problems and their associated factors of people with psychotic disordersJosephien Leonie Jansen, Vera Verhage, Richard Bruggeman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 21, 2007
Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind studyChristina W Slotema, Peter N van Harten, Richard Bruggeman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2017
Effects of low frequency rTMS treatment on brain networks for inner speech in patients with schizophrenia and auditory verbal hallucinationsLeonie Bais, Edith Liemburg, Ans Vercammen, et al.
Plos One|December 5, 2014
The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysisJojanneke Bruins, Frederike Jörg, Richard Bruggeman, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Case Reports in Psychiatry|August 31, 2012
The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case ReportKhalid Abou Farha, Andre van Vliet, Henderikus Knegtering, et al.
BMC Psychiatry|March 23, 2017
Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illnessAnne Looijmans, Frederike Jörg, Richard Bruggeman, et al.
Schizophrenia Bulletin|August 23, 2015
Creating a Supportive Environment: Peer Support Groups for Psychotic DisordersStynke Castelein, Richard Bruggeman, Larry Davidson, et al.
BMC Psychiatry|November 7, 2019
Multimodal lifestyle intervention using a web-based tool to improve cardiometabolic health in patients with serious mental illness: results of a cluster randomized controlled trial (LION)Anne Looijmans, Frederike Jörg, Richard Bruggeman, et al.
Journal of Neuro-Oncology|September 8, 2010
The detection of CMV pp65 and IE1 in glioblastoma multiformeKenneth G Lucas, Lei Bao, Richard Bruggeman, et al.
Neuropsychology|February 17, 2026
Financial competence, situation, and context of people with recent-onset psychosis: A comparison with matched controls and the role of cognitionJosephien Leonie Jansen, Lydia Krabbendam, Oliver Tucha, et al.
International Journal of Qualitative Studies on Health and Well-Being|March 20, 2025
A penny for your thoughts: three perspectives on financial problems and their associated factors of people with psychotic disordersJosephien Leonie Jansen, Vera Verhage, Richard Bruggeman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 21, 2007
Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind studyChristina W Slotema, Peter N van Harten, Richard Bruggeman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2017
Effects of low frequency rTMS treatment on brain networks for inner speech in patients with schizophrenia and auditory verbal hallucinationsLeonie Bais, Edith Liemburg, Ans Vercammen, et al.
Plos One|December 5, 2014
The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysisJojanneke Bruins, Frederike Jörg, Richard Bruggeman, et al.
Pageof 17